| 000 | 01738 a2200493 4500 | ||
|---|---|---|---|
| 005 | 20250516202448.0 | ||
| 264 | 0 | _c20141217 | |
| 008 | 201412s 0 0 eng d | ||
| 022 | _a1944-9917 | ||
| 024 | 7 |
_a10.1210/me.2013-1424 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aErdélyi, László Sándor | |
| 245 | 0 | 0 |
_aAltered agonist sensitivity of a mutant v2 receptor suggests a novel therapeutic strategy for nephrogenic diabetes insipidus. _h[electronic resource] |
| 260 |
_bMolecular endocrinology (Baltimore, Md.) _cMay 2014 |
||
| 300 |
_a634-43 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntidiuretic Agents _xpharmacology |
| 650 | 0 | 4 |
_aCyclic AMP _xmetabolism |
| 650 | 0 | 4 | _aDNA Mutational Analysis |
| 650 | 0 | 4 |
_aDeamino Arginine Vasopressin _xpharmacology |
| 650 | 0 | 4 |
_aDiabetes Insipidus, Nephrogenic _xdrug therapy |
| 650 | 0 | 4 | _aEndoplasmic Reticulum |
| 650 | 0 | 4 | _aHEK293 Cells |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aIn Vitro Techniques |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 | _aMutation, Missense |
| 650 | 0 | 4 |
_aNeurophysins _xpharmacology |
| 650 | 0 | 4 |
_aProtein Precursors _xpharmacology |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 |
_aReceptors, Vasopressin _xagonists |
| 650 | 0 | 4 | _aSecond Messenger Systems |
| 650 | 0 | 4 |
_aVasopressins _xpharmacology |
| 700 | 1 | _aBalla, András | |
| 700 | 1 | _aPatócs, Attila | |
| 700 | 1 | _aTóth, Miklós | |
| 700 | 1 | _aVárnai, Péter | |
| 700 | 1 | _aHunyady, László | |
| 773 | 0 |
_tMolecular endocrinology (Baltimore, Md.) _gvol. 28 _gno. 5 _gp. 634-43 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1210/me.2013-1424 _zAvailable from publisher's website |
| 999 |
_c23639490 _d23639490 |
||